References
- Rodriguez-WallbergKAOktayKFertility preservation during cancer treatment: clinical guidelinesCancer Manag Res2014610511724623991
- Rodriguez-WallbergKAAlonso de MenaSMalmELarssonAKuiperRHassanMPre-pubertal status does not protect against follicle depletion induced by cyclophosphamide in mice. A randomized studyHum Reprod201328Suppl 1321
- KishkEAMohammed AliMHEffect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult miceArch Gynecol Obstet201328751023102923224696
- HenesJCHenesMvon WolffMSchmalzingMKötterILawrenzBFertility preservation in women with vasculitis: experiences from the FertiPROTEKT networkClin Exp Rheumatol2012301 Suppl 70S53S5622512886
- BehringerKThielenIMuellerHFertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trialAnn Oncol20122371818182522228451
- BlumenfeldZKatzGEvronA‘An ounce of prevention is worth a pound of cure’: the case for and against GnRH-agonist for fertility preservationAnn Oncol3202014 [Epub ahead of print.]
- Del MastroLCeppiMPoggioFGonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trialsCancer Treat Rev201440567568324360817
- SunXDongolSJiangJKongBProtection of ovarian function by GnRH agonists during chemotherapy: a meta-analysisInt J Oncol20144441335134024535045
- YangB1ShiWYangJConcurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trialsBreast201322215015723298851
- ChenH1LiJCuiTHuLAdjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal womenCochrane Database Syst Rev201111CD00801822071842
- ClowseMEBeheraMAAndersCKOvarian preservation by GnRH agonists during chemotherapy: a meta-analysisJ Womens Health (Larchmt)200918331131919281314
- WongMO’NeillSWalshGSmithIEGoserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomesAnn Oncol201324113313823019276
- DemeestereIBricePPeccatoriFAGonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trialJ Clin Oncol201331790390923129737
References
- Rodriguez-WallbergKAOktayKFertility preservation during cancer treatment: clinical guidelinesCancer Manag Res2014610511724623991
- LetourneauJMKatzPMSmithJFOktayKCedarsMIRosenMPThe prevalence of self-reported reproductive impairment in young female cancer survivors throughout CaliforniaFertil Steril2010944510
- GerberBEffect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyJ Clin Oncol201129172334234121537042
- ElgindyEAEl-HaiegDOKhorshidOMIsmailEAbou-SettaAMSallamHNGonadotropin-releasing hormone analogue cotreatment does not preserve ovarian function in young women receiving cyclophosphamide-based chemotherapy: a prospective, multicenter, randomized trialFertil Steril201196Suppl 3S47S48
- MunsterPNRandomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancerJ Clin Oncol201230553353822231041
- Rodriguez-WallbergKAAlonso de MenaSMalmELarssonAKuiperRHassanMPre-pubertal status does not protect against follicle depletion induced by cyclophosphamide in mice. A randomized studyHum Reprod201328Suppl 1321
- LeeSJAmerican Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer PatientsJ Clin Oncol200624182917293116651642
- LorenAWFertility Preservation for Patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateJ Clin Oncol201331192500251023715580